comparemela.com

Latest Breaking News On - Calt - Page 3 : comparemela.com

Calliditas Therapeutics AB (publ) (CALT) Set to Announce Quarterly Earnings on Wednesday

Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Free Report) is scheduled to release its 12/31/2023 earnings data before the market opens on Wednesday, February 21st. Analysts expect Calliditas Therapeutics AB (publ) to post earnings of ($0.09) per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do […]

Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Shares Gap Down to $25 00

Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Free Report)’s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $25.00, but opened at $24.01. Calliditas Therapeutics AB (publ) shares last traded at $23.85, with a volume of 4,324 shares traded. Wall Street Analyst Weigh In Separately, HC Wainwright reiterated […]

Calliditas Therapeutics stock jumps as kidney treatment gets FDA approval

Calliditas Therapeutics AB’s American depositary receipts jumped 15% premarket on Thursday after the company said late Wednesday that its kidney treatment.

Micron, Warner Bros Discovery, BlackBerry, Boeing, Toyota, and More Stock Market Movers

HC Wainwright Reiterates Buy Rating for Calliditas Therapeutics AB (publ) (NASDAQ:CALT)

HC Wainwright reaffirmed their buy rating on shares of Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Free Report) in a research note published on Monday, Benzinga reports. They currently have a $50.00 price target on the stock. Separately, Guggenheim lowered their price target on shares of Calliditas Therapeutics AB (publ) from $21.00 to $18.00 and set […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.